Provided by Tiger Trade Technology Pte. Ltd.

iShares Global Healthcare ETF

100.55
-0.3150-0.31%
Volume:17.96K
Turnover:1.81M
Market Cap:4.24B
PE:-97.78
High:101.08
Open:100.85
Low:100.51
Close:100.86
52wk High:107.69
52wk Low:90.24
Shares:42.15M
Float Shares:42.15M
Volume Ratio:0.92
T/O Rate:0.04%
Dividend:1.44
Dividend Rate:1.43%
EPS(TTM):-1.0283
EPS(LYR):-1.0283
ROE:-8.66%
ROA:0.90%
PB:1.09
PE(LYR):-97.78

Loading ...

Merck Starts Phase 1 Trial of Oral Peptide Developed With Cyprumed's Technology

MT Newswires Live
·
Sep 29

Lilly Touts Foundayo Advantage over Novo's Ozempic Pill in Diabetes Analysis

Reuters
·
Sep 29

Analysts’ Top Healthcare Picks: AbbVie (ABBV), Quantum-Si (QSI)

TIPRANKS
·
Sep 29

Novo Nordisk Says Ozempic Shows Lower Risk of Cardiovascular Events Compared to Eli Lilly's Mounjaro

Reuters
·
Sep 29

Eli Lilly announces positive results from study of Foundayo 17.2 mg

TIPRANKS
·
Sep 29

Goldman Sachs Names 2 Undervalued Healthcare Stocks to Buy With At Least 50% Upside

TIPRANKS
·
Sep 29

Scotiabank Adjusts PT on Merck & Co. to $180 From $155, Keeps Sector Outperform Rating

MT Newswires Live
·
Sep 29

Cyprumed : Eligible to Receive up to $493.00m in Milestones from Merck & Co Collaboration

THOMSON REUTERS
·
Sep 29

Eli Lilly's Foundayo 17.2 Mg was Associated with 1.5% Greater Weight Loss at 52 Weeks

Reuters
·
Sep 29

Lilly Says Foundayo 17.2 Mg Outperforms Oral Semaglutide 25 Mg on Weight Loss, A1C in Indirect Comparison Study

Reuters
·
Sep 29

Eli Lilly - Foundayo 17.2 Mg Shows 1.5% Greater Weight Loss and 0.3% Greater A1c Reduction at 52 Weeks

THOMSON REUTERS
·
Sep 29

Merck & Co Inc : Scotiabank Raises Target Price to $180 from $155

THOMSON REUTERS
·
Sep 29

Judge Rejects Pfizer, BioNTech, and Moderna Bid to Dismiss Monsanto mRNA Patent Lawsuit

Stock News
·
Sep 29

Perrigo Co. PLC Stock Underperforms Monday When Compared to Competitors

Dow Jones
·
Sep 29

Estee Lauder Cos. Cl a Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Sep 29

Sector Update: Healthcare

MT Newswires Live
·
Sep 29

Market Chatter: Eli Lilly CEO Plans Larger Deals to Target New Disease Areas

MT Newswires Live
·
Sep 29

Lilly CEO Eyes Bigger Deals in Hunt for Pharma's 'white Spaces' - Bloomberg News

Reuters
·
Sep 29

Robert Hunter to be New UnitedHealthcare President

Reuters
·
Sep 29

Eli Lilly CEO tells Bloomberg sees more deals in untapped areas

TIPRANKS
·
Sep 29